vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Grindr Inc. (GRND). Click either name above to swap in a different company.
Grindr Inc. is the larger business by last-quarter revenue ($126.0M vs $83.5M, roughly 1.5× BillionToOne, Inc.). Grindr Inc. runs the higher net margin — 16.1% vs 6.8%, a 9.2% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 29.0%). Grindr Inc. produced more free cash flow last quarter ($24.5M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Grindr is a location-based social networking and online hookup application for LGBTQ people.
BLLN vs GRND — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $126.0M |
| Net Profit | $5.7M | $20.3M |
| Gross Margin | 69.9% | — |
| Operating Margin | 11.5% | 24.9% |
| Net Margin | 6.8% | 16.1% |
| Revenue YoY | 117.4% | 29.0% |
| Net Profit YoY | 138.3% | 116.4% |
| EPS (diluted) | $0.10 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $126.0M | ||
| Q3 25 | $83.5M | $115.8M | ||
| Q2 25 | — | $104.2M | ||
| Q1 25 | — | $93.9M | ||
| Q4 24 | $45.1M | $97.6M | ||
| Q3 24 | $38.4M | $89.3M | ||
| Q2 24 | — | $82.3M | ||
| Q1 24 | — | $75.3M |
| Q4 25 | — | $20.3M | ||
| Q3 25 | $5.7M | $30.8M | ||
| Q2 25 | — | $16.6M | ||
| Q1 25 | — | $27.0M | ||
| Q4 24 | $-11.5M | $-123.9M | ||
| Q3 24 | $-14.9M | $24.7M | ||
| Q2 24 | — | $-22.4M | ||
| Q1 24 | — | $-9.4M |
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 57.1% | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 24.9% | ||
| Q3 25 | 11.5% | 39.1% | ||
| Q2 25 | — | 23.4% | ||
| Q1 25 | — | 27.0% | ||
| Q4 24 | 17.0% | 20.9% | ||
| Q3 24 | -32.9% | 31.8% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | 25.6% |
| Q4 25 | — | 16.1% | ||
| Q3 25 | 6.8% | 26.6% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 28.8% | ||
| Q4 24 | -25.5% | -126.9% | ||
| Q3 24 | -38.8% | 27.6% | ||
| Q2 24 | — | -27.2% | ||
| Q1 24 | — | -12.5% |
| Q4 25 | — | $0.10 | ||
| Q3 25 | $0.10 | $0.16 | ||
| Q2 25 | — | $0.08 | ||
| Q1 25 | — | $0.09 | ||
| Q4 24 | $-1.13 | $-0.65 | ||
| Q3 24 | $-1.47 | $0.09 | ||
| Q2 24 | — | $-0.13 | ||
| Q1 24 | — | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $87.0M |
| Total DebtLower is stronger | $55.0M | $395.9M |
| Stockholders' EquityBook value | $-239.5M | $47.0M |
| Total Assets | $327.5M | $531.0M |
| Debt / EquityLower = less leverage | — | 8.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $87.0M | ||
| Q3 25 | $195.2M | $6.3M | ||
| Q2 25 | — | $120.8M | ||
| Q1 25 | — | $255.9M | ||
| Q4 24 | $191.5M | $59.2M | ||
| Q3 24 | — | $39.1M | ||
| Q2 24 | — | $16.3M | ||
| Q1 24 | — | $21.5M |
| Q4 25 | — | $395.9M | ||
| Q3 25 | $55.0M | $279.9M | ||
| Q2 25 | — | $283.5M | ||
| Q1 25 | — | $287.0M | ||
| Q4 24 | $51.5M | $290.6M | ||
| Q3 24 | — | $294.1M | ||
| Q2 24 | — | $297.7M | ||
| Q1 24 | — | $315.0M |
| Q4 25 | — | $47.0M | ||
| Q3 25 | $-239.5M | $71.0M | ||
| Q2 25 | — | $187.7M | ||
| Q1 25 | — | $319.8M | ||
| Q4 24 | $-251.7M | $-131.6M | ||
| Q3 24 | $-242.9M | $-13.4M | ||
| Q2 24 | — | $-41.7M | ||
| Q1 24 | — | $-22.0M |
| Q4 25 | — | $531.0M | ||
| Q3 25 | $327.5M | $439.2M | ||
| Q2 25 | — | $547.6M | ||
| Q1 25 | — | $679.4M | ||
| Q4 24 | $302.1M | $479.1M | ||
| Q3 24 | — | $456.3M | ||
| Q2 24 | — | $435.0M | ||
| Q1 24 | — | $437.7M |
| Q4 25 | — | 8.42× | ||
| Q3 25 | — | 3.94× | ||
| Q2 25 | — | 1.51× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $24.8M |
| Free Cash FlowOCF − Capex | $6.5M | $24.5M |
| FCF MarginFCF / Revenue | 7.7% | 19.5% |
| Capex IntensityCapex / Revenue | 8.8% | 0.2% |
| Cash ConversionOCF / Net Profit | 2.42× | 1.22× |
| TTM Free Cash FlowTrailing 4 quarters | — | $140.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $24.8M | ||
| Q3 25 | $13.8M | $55.4M | ||
| Q2 25 | — | $37.5M | ||
| Q1 25 | — | $23.8M | ||
| Q4 24 | — | $29.5M | ||
| Q3 24 | — | $29.1M | ||
| Q2 24 | — | $15.8M | ||
| Q1 24 | — | $20.4M |
| Q4 25 | — | $24.5M | ||
| Q3 25 | $6.5M | $55.2M | ||
| Q2 25 | — | $37.3M | ||
| Q1 25 | — | $23.7M | ||
| Q4 24 | — | $29.3M | ||
| Q3 24 | — | $28.8M | ||
| Q2 24 | — | $15.7M | ||
| Q1 24 | — | $20.3M |
| Q4 25 | — | 19.5% | ||
| Q3 25 | 7.7% | 47.7% | ||
| Q2 25 | — | 35.8% | ||
| Q1 25 | — | 25.2% | ||
| Q4 24 | — | 30.0% | ||
| Q3 24 | — | 32.2% | ||
| Q2 24 | — | 19.0% | ||
| Q1 24 | — | 26.9% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | 8.8% | 0.2% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 1.22× | ||
| Q3 25 | 2.42× | 1.80× | ||
| Q2 25 | — | 2.25× | ||
| Q1 25 | — | 0.88× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.18× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
GRND
| License And Service | $102.9M | 82% |
| Advertising | $23.1M | 18% |
